Literature DB >> 31079262

Third Time's a Charm: Immunization Strategies for Hepatitis B in Immunosuppressed Patients with Inflammatory Bowel Disease.

Dana Ley1, Mary S Hayney2, Freddy Caldera3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31079262     DOI： 10.1007/s10620-019-05662-y

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN： 0163-2116            Impact factor:   3.487


× No keyword cloud information.
  8 in total

Review 1.  ACG Clinical Guideline: Preventive Care in Inflammatory Bowel Disease.

Authors:  Francis A Farraye; Gil Y Melmed; Gary R Lichtenstein; Sunanda V Kane
Journal:  Am J Gastroenterol       Date:  2017-01-10       Impact factor: 10.864

2.  Antibody Response to Hepatitis B Virus Vaccine is Impaired in Patients With Inflammatory Bowel Disease on Infliximab Therapy.

Authors:  Perry K Pratt; Nunes David; Horst C Weber; Frédéric F Little; Themistoklis Kourkoumpetis; Gregory J Patts; Janice Weinberg; Francis A Farraye
Journal:  Inflamm Bowel Dis       Date:  2018-01-18       Impact factor: 5.325

3.  Lower Sustained Diphtheria and Pertussis Antibody Concentrations in Inflammatory Bowel Disease Patients.

Authors:  Freddy Caldera; Sumona Saha; Arnold Wald; Christine A Garmoe; Sue McCrone; Bryant Megna; Dana Ley; Mark Reichelderfer; Mary S Hayney
Journal:  Dig Dis Sci       Date:  2018-03-29       Impact factor: 3.199

Review 4.  Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease.

Authors:  J P Gisbert; M Chaparro; M Esteve
Journal:  Aliment Pharmacol Ther       Date:  2011-03       Impact factor: 8.171

5.  Normal response to vaccines in inflammatory bowel disease patients treated with thiopurines.

Authors:  Iris Dotan; Lael Werner; Sharon Vigodman; Shradha Agarwal; Jorge Pfeffer; Noya Horowitz; Lisa Malter; Maria Abreu; Thomas Ullman; Hanan Guzner-Gur; Zamir Halpern; Lloyd Mayer
Journal:  Inflamm Bowel Dis       Date:  2011-03-15       Impact factor: 5.325

6.  Antibody Levels and Protection After Hepatitis B Vaccine: Results of a 30-Year Follow-up Study and Response to a Booster Dose.

Authors:  Michael G Bruce; Dana Bruden; Debby Hurlburt; Carolyn Zanis; Gail Thompson; Lisa Rea; Michele Toomey; Lisa Townshend-Bulson; Karen Rudolph; Lisa Bulkow; Philip R Spradling; Richard Baum; Thomas Hennessy; Brian J McMahon
Journal:  J Infect Dis       Date:  2016-01-21       Impact factor: 5.226

7.  Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant.

Authors:  Sarah Schillie; Aaron Harris; Ruth Link-Gelles; José Romero; John Ward; Noele Nelson
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-04-20       Impact factor: 17.586

8.  Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.

Authors:  Sarah Schillie; Claudia Vellozzi; Arthur Reingold; Aaron Harris; Penina Haber; John W Ward; Noele P Nelson
Journal:  MMWR Recomm Rep       Date:  2018-01-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.